{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-205794","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2022-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.719544+00:00","generated_at":"2026-06-24T07:04:40.982611+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"TherapeuticsMD extends loan maturity to July 29, 2022; evaluating Chapter 11 protection","bullets":["Maturity date of Financing Agreement amended to July 29, 2022, a one-day extension from the amendment date.","Company's board evaluating all options for capital structure, including refinancing and potential Chapter 11 filing.","Company states it intends to maintain normal operations during evaluation.","Amendment indicates near-term liquidity stress and risk of bankruptcy."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-205794","json":"https://secwatch.observer/filing/0001193125-22-205794.json","markdown":"https://secwatch.observer/filing/0001193125-22-205794.md","text":"https://secwatch.observer/filing/0001193125-22-205794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000119312522205794/0001193125-22-205794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000119312522205794/d356099d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T07:04:40.982611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}